​

NEXGEL Stock (NASDAQ:NXGL)

RevenueOwnershipFinancialsChartTranscripts
NEXGEL by TradingView

Previous Close

$2.54

52W Range

$1.84 - $5.10

50D Avg

$3.02

200D Avg

$3.04

Market Cap

$28.16M

Avg Vol (3M)

$64.59K

Beta

0.63

Div Yield

-

NXGL Company Profile

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

19

IPO Date

Dec 22, 2021

Website

NXGL Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 24Dec 23
Contract Manufacturing$1.98M$1.98M
Other Incomes$243.00K$76.00K

Fiscal year ends in Dec 24 | Currency in USD

NXGL Financial Summary

Dec 24Dec 23Dec 22
Revenue$8.69M$4.09M$2.05M
Operating Income$-3.55M$-3.48M$-3.35M
Net Income$-3.28M$-3.16M$-6.14M
EBITDA$-3.55M$-2.73M$-3.11M
Basic EPS$-0.50$-0.56$-1.10
Diluted EPS$-0.50$-0.56$-1.10

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q4 24Mar 24, 25 | 4:30 PM
Q3 24Nov 13, 24 | 4:30 PM
Q2 24Aug 14, 24 | 4:30 PM

Peer Comparison

TickerCompany
POAIPredictive Oncology Inc.
LUCYInnovative Eyewear, Inc.
PDEXPro-Dex, Inc.
NYXHNyxoah S.A.
AVGRAvinger, Inc.
DXRDaxor Corporation
ZJYLJin Medical International Ltd.
STSSSharps Technology, Inc.
GCTKGlucoTrack, Inc.